7Baggers
Quarterly
Annual
    Unit: USD2023-12-29 2022-12-30 2021-12-31 2020-01-01 2018-12-28 2017-12-29 2016-12-30 2015-01-01 2014-01-02 2012-12-28 2011-12-30 2011-09-30 2011-07-01 2011-04-01 2010-12-31 2010-10-01 2010-07-02 2010-04-02 2010-01-01 2009-10-02 2009-07-03 2009-04-03 2009-01-02 2008-09-26 2008-06-27 2008-03-28 2007-12-28 2007-09-28 2007-06-29 2007-03-30 2006-12-29 2006-09-29 2006-06-30 2006-03-31 2005-12-30 
      
                                       
      cash flow from operating activities:
                                       
      net income
    63,000,000 85,600,000 115,300,000 155,500,000 86,800,000 -34,900,000 37,700,000 -37,327,000 55,383,000 32,679,000 28,663,000 27,196,000 54,178,000 38,872,000 35,848,000 32,842,000 6,771,000 28,152,000 9,269,000 15,847,000 21,150,000 17,697,000 13,739,000 39,067,000 48,599,000 40,067,000 26,291,000 27,374,000 35,026,000 28,683,000 23,985,000 25,342,000 28,503,000 25,828,000  
      adjustments to reconcile net income to net cash from operating activities:
                                       
      depreciation and amortization
                                       
      deferred income taxes
    -600,000 1,300,000 -18,000,000 -57,300,000  1,600,000 -800,000 2,093,000 11,870,000 -2,015,000 -16,130,000 -6,036,000 -2,746,000 -1,393,000 -11,091,000 634,000 -4,564,000 103,000 1,795,000 -5,862,000 -1,800,000 -1,606,000 -3,121,000   -885,000 12,915,000 2,089,000 -2,234,000 -6,402,000 10,723,000 1,323,000 202,000 -1,880,000  
      stock-based compensation
    32,900,000 27,200,000 27,500,000 30,900,000 23,800,000 19,800,000 12,600,000 17,975,000 17,240,000 9,032,000 7,418,000 7,106,000 7,129,000 6,798,000 6,960,000 5,540,000 4,984,000 5,641,000 5,338,000 4,541,000 4,554,000 4,226,000 4,563,000 3,826,000 3,795,000 3,982,000 4,067,000 3,804,000 3,792,000 3,353,000 3,134,000 2,948,000 3,259,000 3,230,000  
      divestitures gain
    1,400,000 4,100,000                                  
      other
    17,500,000 19,000,000 13,500,000 12,200,000 -200,000 300,000 1,000,000 5,832,000 -3,111,000 675,000 2,153,000 189,000 -401,000 44,000 6,000 32,000 66,000 1,000 -2,657,000 134,000 -527,000 14,000 -194,000 -291,000 180,000 -43,000 290,000 -17,000 225,000 153,000 589,000 -131,000 -166,000 428,000  
      increase in assets:
                                       
      accounts receivable
    -60,400,000 -68,600,000 -42,700,000 -30,800,000 -35,200,000 -7,400,000 11,100,000 13,042,000 17,584,000 15,108,000 11,243,000 -12,467,000 9,974,000 -40,624,000 9,654,000 -1,632,000 16,148,000 -31,546,000 -6,548,000 -1,504,000 22,829,000 -18,712,000 49,644,000   -39,280,000 7,275,000 -1,139,000 -13,570,000 -28,262,000 7,644,000 -412,000 6,794,000 -26,211,000  
      inventories
    21,300,000 -14,000,000 -44,500,000 -6,700,000 -16,000,000 -19,300,000 -1,700,000 24,334,000 -34,423,000 -3,752,000 -18,795,000 4,756,000 -7,383,000 -8,717,000 -13,000,000 -12,802,000 -10,306,000 -9,441,000 11,992,000 8,856,000 -229,000 -7,327,000 -296,000   -3,437,000 -3,166,000 -3,752,000 -10,735,000 -1,025,000 3,068,000 -582,000 -8,730,000 5,870,000  
      other current and non-current assets
    -31,700,000 -14,600,000 12,300,000 -7,900,000 -6,900,000 2,800,000 9,900,000 5,329,000 15,664,000 -5,101,000 3,514,000 5,527,000 -3,449,000 4,927,000 1,891,000 -637,000 3,106,000 -2,103,000 -2,535,000 -374,000 1,559,000 730,000 980,000   -191,000 1,297,000 -3,061,000 -1,753,000 11,167,000 -11,565,000 -5,030,000 4,730,000 -6,827,000  
      increase in liabilities:
                                       
      accounts payable
    -17,400,000 -21,000,000 9,500,000 -29,300,000 -11,200,000 -1,900,000 8,200,000 345,000 15,282,000 18,157,000 -6,349,000 -6,737,000 -7,601,000 16,377,000 -2,219,000 -1,519,000 -10,004,000 27,319,000 3,699,000 -5,858,000 -7,892,000 12,682,000 -19,039,000 -6,496,000 877,000 3,760,000 3,997,000 -1,220,000 -9,563,000 3,265,000 1,763,000 -7,636,000 -2,975,000 4,361,000  
      accrued compensation and benefits
    8,500,000 -1,300,000 29,000,000 87,200,000 32,400,000 26,200,000 13,400,000 9,221,000 3,265,000 1,514,000 4,390,000 3,532,000 4,788,000 -10,241,000 148,000 7,638,000 3,401,000 4,741,000 -2,028,000 -535,000 417,000 2,391,000 -5,061,000   -10,557,000    -11,618,000 5,619,000 1,003,000 7,786,000 -6,601,000  
      deferred revenue
    65,700,000 94,300,000 35,800,000 32,300,000 22,500,000 -13,200,000 -6,700,000 -13,761,000 -1,026,000 4,170,000 11,137,000 -950,000 9,807,000 -1,219,000 -3,159,000 1,306,000 -4,792,000 5,468,000 14,723,000 3,529,000 3,117,000 4,107,000 -4,182,000 -1,112,000 1,940,000 2,034,000  13,857,000 8,836,000 3,296,000  -363,000 4,452,000 5,410,000  
      income taxes payable
    -66,500,000                      -15,394,000 5,187,000 -2,454,000 12,547,000 -14,958,000 -119,000 20,668,000 12,962,000 2,750,000 -142,000 288,000 7,336,000  
      other current and non-current liabilities
    -200,000 -49,700,000 -26,000,000 -39,300,000                                
      net cash from operating activities
    98,900,000 106,100,000 155,300,000 209,200,000 101,900,000 101,900,000 125,100,000 44,436,000 128,675,000 96,806,000 79,808,000 51,105,000 82,789,000 27,927,000 36,998,000 -8,277,000 39,806,000 55,503,000 55,510,000 30,447,000 65,513,000 43,161,000 34,129,000 41,582,000 79,644,000 20,719,000 57,901,000 42,627,000 54,710,000 31,747,000 52,320,000 26,398,000 42,492,000 16,877,000  
      capex
    -9,800,000 -6,600,000 -14,700,000 -14,500,000 -17,300,000 -6,300,000 -8,948,000 10,334,000 -19,945,000 -7,276,000 -6,680,000 -5,286,000 -4,036,000 -5,971,000 -6,132,000 -5,731,000 -5,299,000 -2,126,000 -4,154,000 -3,261,000 -3,711,000 -2,938,000 -3,873,000 -2,563,000 -3,023,000 -5,971,000 -4,972,000  
      free cash flows
    89,100,000 99,500,000 140,600,000 209,200,000 87,400,000 84,600,000 118,800,000 35,488,000 139,009,000 76,861,000 72,532,000 44,425,000 77,503,000 23,891,000 31,027,000 -14,409,000 34,075,000 50,204,000 55,510,000 28,321,000 61,359,000 39,900,000 34,129,000 41,582,000 79,644,000 17,008,000 57,901,000 39,689,000 54,710,000 27,874,000 49,757,000 23,375,000 36,521,000 11,905,000  
      cash flow from investing activities:
                                       
      divestiture of businesses, net of cash divested
                                       
      acquisitions of businesses, net of cash acquired
    -55,400,000 -234,900,000 -173,300,000 -22,100,000 -6,400,000 -16,500,000 14,563,000 -107,544,000 -372,630,000 -1,494,000 -666,794,000 -52,470,000 -38,979,000 -45,662,000 -57,152,000 -12,034,000 -21,571,000 -1,194,000 -11,795,000 -21,735,000 -17,294,000 -45,827,000   -39,593,000 -10,325,000 -7,780,000        
      purchases of property and equipment
    -9,800,000 -6,600,000 -14,700,000                                 
      net cash from investing activities
    -3,700,000 -74,100,000 -254,500,000 -163,100,000 -36,800,000 -43,100,000 -65,800,000 30,043,000 -87,638,000 -376,324,000 -1,719,000 -677,385,000 -51,240,000 -43,221,000 -47,237,000 -48,429,000 -30,792,000 -29,916,000 2,761,000 -12,891,000 -27,254,000 -46,542,000 -44,087,000   -43,347,000 -19,910,000 -8,428,000 -7,143,000 -275,911,000 -59,283,000 -8,069,000 -41,836,000 -7,244,000  
      cash flow from financing activities:
                                       
      issuance of common stock, net of tax withholdings
    -1,300,000 -8,800,000 -16,200,000 -18,400,000 -12,100,000 800,000                              
      repurchases of common stock
       -40,000,000                               
      proceeds from debt and revolving credit lines
    448,300,000 285,500,000 355,800,000 384,400,000 269,000,000 64,000,000 512,973,000 544,145,000                           
      payments on debt and revolving credit lines
    -436,100,000 -354,300,000 -28,200,000 -452,400,000 -425,700,000 -51,100,000 -114,000,000 -401,926,000 -459,240,000                           
      net cash from financing activities
    -89,200,000 -84,000,000 -84,500,000 -23,100,000 -93,600,000 44,900,000 -48,300,000 -94,270,000 10,871,000 295,098,000 -63,996,000 520,156,000 -27,463,000 35,470,000 20,300,000   9,077,000 1,316,000 8,879,000 1,307,000 4,623,000 90,760,000   -15,707,000 -17,260,000 -23,097,000 -38,494,000 182,667,000    11,100,000  
      effect of exchange rate changes on cash and cash equivalents
    10,000,000 14,300,000 -3,800,000 13,400,000 -4,400,000 -200,000 -8,400,000 -4,459,000 -8,621,000 351,000 2,273,000 -5,432,000 1,383,000 3,378,000 -329,000 5,241,000 -4,025,000 -1,439,000 -838,000 3,510,000 3,761,000 -1,946,000 -3,750,000 -4,926,000 -1,444,000 6,512,000 -1,601,000 -790,000 1,116,000 -4,553,000 -2,669,000 191,000 -633,000 3,062,000  
      net increase in cash and cash equivalents
     -37,700,000 -187,500,000 36,400,000 -32,900,000 103,500,000 2,600,000      5,469,000 23,554,000 9,732,000 -50,604,000 -45,413,000 33,225,000 58,749,000 29,945,000       19,130,000 10,312,000 10,189,000 -66,050,000 -6,781,000 28,676,000 10,078,000 23,795,000 -13,440,000 
      cash and cash equivalents - beginning of period
                                      
      cash and cash equivalents - end of period
    16,000,000                                   
      supplemental cash flow disclosure:
                                       
      cash paid for income taxes, excluding tax for the ag divestiture
                                       
      cash tax paid for the ag divestiture
                                       
      non-cash equity investments
                                       
      includes 9.0 million, 17.1 million, and 9.1 million of cash and cash equivalents classified as held for sale as of january 3, 2025, september 27, 2024, and december 29, 2023.
                                       
      includes 9.0 million and 9.1 million of cash and cash equivalents classified as held for sale as of january 3, 2025 and december 29, 2023.
                                       
      cash paid for income taxes
                                       
      includes 9.0 million, 6.5 million, and 9.1 million of cash and cash equivalents classified as held for sale as of january 3, 2025, march 29, 2024, and december 29, 2023.
                                       
      proceeds from divestitures
                                       
      cash tax paid, net, excluding tax for the ag divestiture
                                       
      includes 17.1 million, 9.1 million, and 6.1 million of cash and cash equivalents classified as held for sale as of september 27, 2024, december 29, 2023, and september 29, 2023.
                                       
      includes 9.1 million of cash and cash equivalents classified as held for sale as of december 29, 2023.
                                       
      include 6.5 million and 9.1 million of cash and cash equivalents classified as held for sale as of march 29, 2024 and december 29, 2023.
                                       
      cash paid for interest
                                       
      non-cash equity investment
                                       
      depreciation expense
    8,800,000 10,100,000 10,400,000 10,000,000 9,400,000 8,200,000 9,100,000 12,632,000 13,499,000 6,781,000 5,826,000 5,508,000 4,572,000 4,603,000 4,888,000 4,574,000 4,285,000 4,451,000  4,870,000 4,608,000 4,463,000  5,013,000 4,703,000 4,571,000  4,307,000 4,305,000 4,121,000  3,450,000 3,385,000 3,104,000  
      amortization expense
    56,600,000 33,700,000 33,500,000 29,200,000 46,700,000 39,700,000 33,600,000 44,631,000 37,799,000 36,392,000 28,413,000 24,106,000 16,576,000 16,065,000 15,474,000 14,432,000 13,916,000 13,817,000  13,620,000 13,050,000 12,298,000  11,188,000 10,963,000 10,848,000  10,221,000 10,500,000 7,894,000  2,937,000 3,765,000 2,380,000  
      net proceeds from divestitures
    1,900,000 1,100,000                                  
      net decrease in cash and cash equivalents
                         -704,000    -31,823,000          
      change in fair value of derivatives
                                       
      cash flows from operating activities
                                       
      cash flows from financing activities:
                                       
      cash and cash equivalents - beginning of year
                                       
      cash and cash equivalents - end of year
                                       
      net proceeds from sale of property and equipment
      100,000                                 
      net proceeds from sale of businesses
                                      
      divestitures (gain) loss
      -300,000                                 
      repurchase of common stock
                                       
      benefit from credit losses
                                       
      income from equity method investments, net of dividends
                                       
      benefit from doubtful accounts
         500,000 -987,000 2,543,000 602,000 959,000 314,000 281,000 359,000 -702,000 426,000 1,558,000 1,038,000 1,206,000 -120,000 841,000 2,212,000 2,112,000 478,000 81,000 38,000 726,000 326,000 70,000 288,000 -18,000 86,000 -265,000 360,000  
      non-cash restructuring expense
                                 1,391,000      
      benefit from excess and obsolete inventories
         1,900,000 3,800,000 8,747,000 3,266,000 -138,000 1,495,000 2,184,000 2,242,000 2,489,000 1,179,000 400,000 1,271,000 1,902,000 587,000 10,000 2,029,000 904,000 1,754,000 -611,000 1,180,000 2,103,000 839,000 1,572,000        
      acquisitions of property and equipment
        -14,500,000 -17,300,000 -6,300,000 -8,948,000 10,334,000 -19,945,000 -7,276,000 -6,680,000 -5,286,000 -4,036,000 -5,971,000 -6,132,000 -5,731,000 -5,299,000  -2,126,000 -4,154,000 -3,261,000    -3,711,000  -2,938,000        
      (income) income from equity method investments, net of dividends
                                       
      purchases of short-term investments
        -68,000,000                              
      proceeds from maturities of short-term investments
        37,500,000                              
      proceeds from sales of short-term investments
        5,600,000                              
      cash and cash equivalents - beginning of fiscal year
                                       
      cash and cash equivalents - end of fiscal year
                                       
      income from equity method investments
        2,100,000 -6,700,000 -3,700,000 -6,372,000 3,540,000 -5,019,000   -3,418,000 -2,763,000 -2,770,000 -3,404,000                    
      other non-cash items
        7,800,000 6,700,000 -600,000 4,578,000 3,915,000 -1,202,000 147,000 707,000 1,454,000 577,000 -980,000 -296,000 -1,574,000 -1,760,000  -182,000 -302,000 -2,058,000  178,000 -201,000 202,000  4,000        
      cash flows from operating activities:
                                       
      add decrease (increase) in assets:
                                       
      add increase in liabilities:
                                       
      other liabilities
        -60,300,000                               
      cash flows from investing activities:
                                       
      cash and cash equivalents, beginning of fiscal year
                                       
      cash and cash equivalents, end of fiscal year
                                       
      decrease (increase) in assets:
                                       
      other receivables
         2,900,000 4,100,000 13,209,000 -6,368,000 2,979,000 16,670,000 7,483,000 212,000 5,776,000 2,327,000 -7,456,000 -413,000 8,060,000 -2,772,000 1,046,000 -244,000 5,486,000 -9,020,000 1,117,000 -35,000 516,000 206,000 1,651,000 1,101,000 1,867,000 2,572,000 2,026,000 -3,176,000 527,000  
      accrued warranty expense
            2,698,000 971,000 242,000                         
      accrued liabilities
              8,377,000 -5,958,000 -1,234,000 4,398,000 218,000 -3,371,000 -24,297,000 2,617,000 2,486,000 -6,644,000 2,790,000 5,801,000 2,458,000   -1,648,000 -3,803,000 -4,048,000 1,153,000 2,063,000 7,218,000 4,872,000 -5,641,000 3,503,000  
      purchases of equity method investments
             -3,000,000      -2,750,000                  
      net proceeds from sales of businesses
                                      
      dividends received from equity method investments
         5,200,000 1,100,000 -5,850,000 24,559,000                           
      divestiture (gain) loss
                                       
      accrued warranty
                                       
      acquisitions of intangible assets
          6,907,000  -375,000 -1,100,000 -316,000 -250,000 -1,438,000 -328,000 -297,000 -838,000 -26,001,000              
      repurchases and retirement of common stock
                                       
      divestiture gain
                                       
      gain on an equity sale
                                       
      excess tax benefit for stock-based compensation
          -1,500,000 11,994,000 -5,295,000 -8,672,000 -3,064,000 -748,000 -2,593,000 -8,357,000 -7,668,000 -559,000 -930,000 -482,000 -149,000 -1,000,000 -283,000 -21,000 -123,000 -11,096,000 7,241,000 -1,992,000 874,000 -7,354,000 -3,736,000 -2,193,000 -673,000 -3,318,000 -829,000 -3,941,000  
      repurchase and retirement of common stock
          -17,300,000 -169,422,000       -13,343,000       -10,037,000   -25,870,000          
      purchases of available-for-sale investments
                                       
      issuances of common stock, net of tax withholdings
                                       
      cash and cash equivalents, beginning of period
               220,788,000  273,848,000  -5,000,000 147,531,000  103,202,000  129,621,000  73,853,000  
      cash and cash equivalents, end of period
               -111,556,000 5,469,000 244,342,000  -50,604,000 -45,413,000 307,073,000  24,945,000 43,327,000 146,827,000  -9,344,000 8,444,000 71,379,000  10,312,000 10,189,000 63,571,000  28,676,000 10,078,000 97,648,000  
      acquisition / divestiture gain
                                       
      purchases of equity investments
                                       
      net proceeds from sale of business
                                       
      dividends received from equity investments
                                       
      issuances of common stock, net of tax withholding
                                       
      payments related to repurchases of common stock
                                       
      acquisition / divestiture (gain)/loss
                                       
      (purchases) sales of equity method investments
           5,439,000                            
      increase in restricted cash
                                       
      issuances of common stock
               9,519,000 2,878,000 27,785,000  14,018,000 9,218,000 8,649,000  7,898,000 1,173,000 4,602,000  6,694,000 6,942,000 8,483,000  12,069,000        
      sale of equity method investments
                                       
      dividends received
             11,038,000 4,898,000   858,000            2,307,000        
      proceeds from long-term debt and revolving credit lines
             720,796,000 32,000,000            100,000,000    250,000,000      
      payments on short-term and long-term debt
              -104,747,000 -48,111,000                        
      proceeds received from noncontrolling interest holder
                                       
      issuance of common stock
                                 10,474,000  6,972,000 10,013,000 7,149,000  
      payments on long-term debt and revolving credit lines
                 -672,000 -32,000 -373,000 -40,000 -54,000 -15,000 -19,000   2,000 -2,000 -60,002,000 -312,000 -20,420,000 -42,520,000 -47,517,000 -80,000,000      
      net maturities of short term investments
                                       
      (income) income from equity method investments
                                       
      income tax payable
                                       
      increase in restricted cash for business acquisition
                                       
      proceeds from long-term debt, net of debt issuance costs
                                       
      net (purchases) maturities of short term investments
                                       
      purchase of equity method investments
                   -2,000,000                    
      net purchases of short term investments
                                       
      net purchases of debt and equity securities
                                       
      net cash provided (used) by financing activities
                                       
      loss (income) from equity method investments
                     -2,474,000                  
      depreciation
                                       
      amortization
                                       
      amortization of debt issuance cost
                            57,000 56,000 56,000 57,000   45,000 45,000    
      in-process research and development
                              2,112,000 930,000 -20,000    
      equity gain from joint ventures
                                       
      acquisition of property and equipment
                                 -3,873,000 -2,563,000 -3,023,000 -5,971,000 -4,972,000  
      net (purchases) maturities of debt and equity securities
                                       
      investment in joint venture
                                       
      capital infusion from minority investor
                                       
      proceeds from dividends
                                       
      issuance of common stock and warrants
                                       
      amortization of debt issuance costs
                       56,000 57,000 56,000              
      income from joint ventures
                       151,000 -352,000 -168,000              
      gain on bargain purchase
                                      
      net purchases of short-term investments
                                       
      purchase of debt and equity securities
                                       
      non-cash restructuring charges
                                      
      equity gain from joint venture
                             -2,015,000  -1,942,000        
      equity (gain) income from joint ventures
                                       
      deferred gain on joint venture
                                       
      deferred revenues
                                       
      adjustments to reconcile net income to net cash from operating activities
                                       
      adjustments to reconcile net income to net cash
                                       
      provided by operating activities:
                                       
      adjustments to reconcile net income to net cash from operating activities, net of effect of acquisitions:
                                       
      excess and obsolescence reserve
                                 1,055,000      
      gain from joint ventures
                                 -2,423,000      
      acquisitions, net of cash acquired
                                 -272,050,000 -56,720,000 -5,030,000    
      costs of capitalized patents
                                       
      net cash provided (used) in financing activities
                                   10,156,000    
      changes in assets and liabilities:
                                       
      cost of acquisitions, net of cash acquired
                                     -2,272,000  
      collection of notes receivable
                                     10,000  
      cash and cash equivalents
                                       
      as a percentage of total assets
                                       
      accounts receivable days sales outstanding
                                       
      inventory turns per year
                                       
      total debt
                                       
      cash from operating activities
                                       
      cash from investing activities
                                       
      cash provided (used) by financing activities
                                       
      other uses of cash
                                       
      dividends received from joint venture
                                       
      proceeds from sale of assets
                                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.